Merakris aims to deliver a first-in-class drug and pioneer a new era within the wound care industry by commercializing ... The biologic therapy, injected below the skin, is being developed to promote ...

Merakris aims to deliver a first-in-class drug and pioneer a new era within the wound care industry by commercializing regenerative medicine for hard-to-heal wounds The biologic therapy, injected ...

The biologic therapy, injected below the skin, is being developed to promote healing of venous leg ulcers ... last wound healing drug was approved by FDA for cutaneous ulcers,” said Chris ...

Merakris Therapeutics is pleased to announce that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial (NCT04647240) of its investigational wound care drug, Dermacyte® Amniotic ...

A 54-year-old man of Persian origin presented to our department with a 1-year history of ulcers on the right leg that had been unresponsive to numerous topical treatments, accompanied by ...

10, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics is pleased to announce that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial (NCT04647240) of its investigational wound ...